URGN - UroGen Pharma Ltd logo

URGN

UroGen Pharma Ltd

Revenue grew 100% of years5Y
Hold

UroGen Pharma Ltd develops and commercializes therapies for urothelial and specialty cancers, focusing on non-surgical treatments. Its key products include Jelmyto and Zusduri, utilizing proprietary RTGel technology for sustained drug delivery in the urinary tract.

⚕️ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago $3,180today

Score Overview

1 Year
Score
Net Growth36.39%
Net TrendGrew
Net Income Consistency
Rev Growth71.91%
Rev TrendGrew
Revenue Consistency
5 Years
Score6.2
Net Growth11.90%
Net Trend60%
Net Income Consistency
Rev Growth292.85%
Rev TrendEvery year
Revenue Consistency
All Time
Score
Net Growth-388.18%
Net Trend44%
Net Income Consistency
Rev Growth23x
Rev Trend78%
Revenue Consistency

See the full market ranking →

UroGen Pharma Ltd fundamental performance

Between 2020 and 2025, revenue grew from $ 11M to $ 109M and net income went from -$ 128M to -$ 153M. Revenue increased in every one of those 5 years; net income in 3.

Across UroGen Pharma Ltd's full reported history, from 2017 to 2025, revenue grew from $ 8M to $ 109M and net income went from -$ 20M to -$ 153M. Revenue increased in 78% of the years measured; net income in 44%.

UroGen Pharma Ltd currently holds a 5-year HDB Score of 6.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-13
$ 48.12
1 Year2025-08-13
$ 20.11139.28%
5 Years2021-08-13
$ 15.13218.04%
All Time2017-05-04
$ 13.98244.21%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 188M-$ 97M$ 107M
2025$ 109M-$ 153M$ 120M
2024$ 90M-$ 126M$ 236M
2023$ 82M-$ 102M$ 136M
2022$ 64M-$ 109M$ 99M
2021$ 48M-$ 110M$ 89M
2020$ 11M-$ 128M$ 102M
2019$ 18K-$ 105M$ 147M
2018$ 1M-$ 75M$ 101M
IPO2017$ 8M-$ 20M$ 73M

Explore beyond URGN

You're looking at UroGen Pharma Ltd. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies